Merv Lincoln’s ground-breaking PhD research “The Usefulness of Accounting Ratios to Describe Levels of Insolvency Risk” uncovered how to use the financial statements of a business to accurately predict both its financial health and the long-term performance of its share price. It is the core of our methodology and a key part of our ongoing success.
A former international athlete for the mile who represented Australia at both the Olympics and Commonwealth Games, Merv went on to become a senior lecturer in Economics and Finance at the University of Melbourne for 21 years. His intellectual rigour and appetite for elite performance remains the benchmark used to inspire our team every day.
After joining us in 1991, Tim introduced Dr Lincoln’s pioneering methodology to private share investors with the development of Stock Doctor – Australia’s premier DIY share market research membership platform. He was appointed Managing Director in 1997 on Dr Lincoln’s retirement, and is also a member of a variety of industry bodies. These include the Australian Institute of Company Directors, Financial Services Institute of Australasia, Australian Shareholders Association, Australian Institute of Credit Management, and the Risk Management Institute of Australasia.
Melissa joined Lincoln in 2007 as their Chief Operating Officer, after holding a number of senior positions within the Australian and overseas Financial Services sector. Melissa is a vital member of our Executive Team, providing leadership in the day-to-day operations of the business including financial, human resources and commercial operations. Melissa is also responsible for steering Lincoln’s corporate planning including contributing to the development and leading the implementation of Lincoln’s Strategic Plan.
Kien leads the Stock Doctor research team and has extensive experience in the investment field, specifically in quantitative research techniques. He was previously a Portfolio Manager and Senior Quantitative Analyst at Patersons Securities for over 10 years, and prior to that, at Russell Investments providing portfolio construction and risk management strategies to large scale institutional clients. With a background in actuarial science, Kien is responsible for the current Stock Doctor research process, including Lincoln’s acclaimed Financial Health methodology. He is a key contributor in evolving our research processes and is a mentor to the Stock Doctor research team.
Matthew joined the business in 2006 and was appointed Portfolio Manager of the Lincoln Managed Investments team in 2010. He is responsible for the day to day management of the Lincoln Australian Growth, Australian Income and U.S. Growth Fund. Matthew has extensive experience analysing Australian equities and is a key member of the Investment Committee. He has played a key role in executing the Fund’s investment strategies and actively contributes to the process of enhancing our methodology and designing new strategies for product development.
Sandy leads our in-house development team, responsible for the ongoing development of Lincoln Indicators’ flagship product Stock Doctor and other projects. He brings together a variety of senior staff from front-end designers, to passionate technical architects to ensure all software systems deliver above expectations.
To discuss the future of your investments in detail, book in a free consultation with a Lincoln representative.
To discuss the future of your investments in detail, book in a free consultation with a Lincoln financial expert.
